Sierra Leone

AFP                                                                                                                     Feb. 23, 2015
Los Angeles  - Early results from an Ebola trial using the experimental drug Avigan (favipiravir) showed Monday it was somewhat effective at saving lives if given early in the illness, but not later.

Early results from an Ebola trial using the experimental drug Avigan (favipiravir) show it is somewhat effective at saving lives if given early in the illness (AFP Photo/George Frey)

The antiviral treatment is being developed by the Japanese company Toyama Chemical, and has been shown safe and effective against some other viruses including influenza, West Nile and yellow fever.

An ongoing clinical trial in Guinea is testing the drug's use in patients with the Ebola virus, which causes severe vomiting, diarrhea and sometimes fatal bleeding.

Results from only 80 people are available so far, but they show that among those who received the drug early in their illness, 15 percent died of Ebola.

Read complete story.

Center for Global Development - cgdev.org -by Karen A. Grépin and Amanda Glassman - February 4, 2015

. . . In a new paper out today in the BMJ, Karen investigated the level and speed of the international response to the Ebola outbreak and contrasted it with the appeals made by international leaders to curb the spread of the disease. Contrary to widespread belief, Karen finds that, overall, the level of donations to the response were actually robust: as of December 31st, 2,104 donors had pledged almost $3 billion towards controlling the epidemic. Notably, this is actually larger than the official appeals for upwards of $1.5 billion. In addition, the data used underestimate total donations, in particular those given by the World Bank, which mobilized at least $1 billion in financing to help support affected countries.

NATIONAL PUBLIC RADIO INTERVIEW by Laura Starecheski                                     Feb. 20, 2015
BARKEDU,  LIBERIA --If you'd like to get an idea of what resilience is all about, take a lesson from Mamuedeh Kanneh.

She lost her husband to Ebola. But she's stayed strong. She's caring for 13 children, her own and orphans whose parents died of the virus.

Mamuedeh Kanneh was married to Laiye Barwor, the man who brought Ebola to Barkedu, Liberia. He died of the virus. She now cares for her children as well as children who lost their parents to the disease. John W. Poole/NPR

Kanneh lives in Barkedu, a village of about 6,000 in northern Liberia. Ebola took more than 150 lives. In her neighborhood there were many deaths, so people in other parts of Barkedu are scared of the orphans.

Kanneh has a strategy to help these children — and the village overall — get back to normal life. She sends the youngsters on errands so people can get used to seeing them and get over their fear. And the children can start to feel they're part of the community again....

NEW YORK TIMES  OP-ED BY Ron Klain, the former White House Ebola response coordinaor                                    FEB. 20, 2015

...The world needs to do a better job of quickly detecting and responding to future outbreaks in unlikely places. The President’s Global Health Security Agenda, the government’s strategy to combat infection disease around the world, will help. But vulnerable countries, including those in Africa, need their own version of our Centers for Disease Control and Prevention, so that they are not so dependent on ours.

For the hardest task of front-line epidemic fighting, our planet is too reliant on courageous and talented — but underfunded, under-equipped and volunteer-dependent — nongovernmental organizations. The world needs a permanent standing force — or a ready reserve that can be quickly organized — of public health emergency responders who have the training, gear and resources to race into a region in the early phases of epidemic control. The United States military cannot do that job every time; future outbreaks might occur in countries where our troops will not be welcomed as they were in West Africa.